Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine versus placebo for fibromyalgia syndrome
2005-001524-37Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of duloxetine in fibromyalgia (FM) (2 arms), sponsored by Eli Lilly and Company. Primary endpoints: Change in pain severity and Patient global improvement. Started May 2005; status: completed.
02
Drugs
duloxetine
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on 2005-001524-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001524-37.